• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA counters study minimizing risk of antimicrobial resistance transference

March 1, 2004
Daniel R. Verdon

Washington, D.C. -A peer-reviewed article raising concern that the banning of antibiotics in food animals may harm both human and animal health, is drawing criticism from the Food and Drug Administration (FDA).

Washington, D.C. -A peer-reviewed article raising concern that the banning of antibiotics in food animals may harm both human and animal health, is drawing criticism from the Food and Drug Administration (FDA).

The report, published in January's Journal of Antimicrobial Chemotherapy, based in London, says there is little scientific evidence that animal antibiotic use has a deleterious effect on human health. The multi-disciplinary panel made the conclusions after a review of more than 250 scientific studies on the subject.

FDA takes issue with the conclusions raised.

Dr. Linda Tollefson, deputy director for CVM, says "FDA has several concerns with the article; we are planning on writing a " 'letter to the editor' to address our major concerns. Because of our concerns, which generally cover the objectivity of the article as well as it accuracy, the article will have no impact on our current approach to antimicrobial resistance."

Dr. Linda Tollefson

Dr. Ian Phillips, MD, principal author and emeritus professor of medical microbiology at the medical school of Guy's and St. Thomas' Hospitals, University of London, says in a prepared statement, "The scientific evidence shows that the actual risk of transfer of antibiotic resistant organisms from animals to humans caused by the use of antibiotics in food animals is extremely small and in some cases zero."

Advertisement

Phillips adds, "The European Union applied the 'precautionary principle' and set aside scientific evidence, and so made decisions about antibiotics that have, in fact, damaged animal health and not provided any benefits to human health. We need to advance science and risk assessments to help make sound, evidence-based and balanced decisions in the United States and around the world."

The report was created by an independent advisory board to the Animal Health Institute (AHI), and includes Phillips, Ron N. Jones, MD, principal investigator of Sentry Antimicrobial Resistance Surveillance program; Mark Casewell, BSc, M.D., FRCP, FRCPath, University of London; Cox; Brad De Groot, M.S., DVM, Ph.D., Kansas State University, Manhattan, KS, and Livestock Information Services, Callaway, NE; Christian Friis, DVM, Ph.D., Royal Veterinary and Agricultural University, Copenhagen, Denmark; Charles Nightingale, MS, Ph.D., Hartford Hospital, University of Connecticut, Hartford, CT; Rodney Preston, Ph.D., Texas Tech University, Lubbock, TX; and John Waddell, DVM, MBA, Sutton Veterinary Clinic, Sutton, Neb. The association represents animal health manufacturers.

Ron N. Jones, MD

Tollefson argues, "There is a great deal of evidence demonstrating an association between antimicrobial use in animals and antimicrobial resistance in humans. The majority of evidence is found in Salmonella and Campylobacter, but instead the authors elect to concentrate on Enterococcus organisms. More importantly, there is accumulating evidence that antimicrobial resistance among bacteria isolated from humans resulting from the use of antimicrobial agents in food animals results in human health consequences."

It is an issue

The panel of experts reviewed more than 250 studies and available data in an attempt to determine whether or not there is a risk to public health by animal agriculture using antibiotics. The conclusions, Waddell adds, are that "the possibility exists that there could be transfer of resistance from animal use to humans, but the probability is very unlikely."

Waddell explains that the literature review also gave the panel a chance to assess the antibiotic resistance trends in Europe following the ban on growth promotants (low-levels of antibiotics used in feed to promote growth). The report suggests that surveillance data from Europe and the United States shows numerous disconnects in the patterns of resistant bacteria in animals and humans, making it unlikely that there is or has been widespread transference of resistant bacteria via the food supply, the panel concludes. Jones explains that since the ban, the number of cases of food-borne illness has increased as well as the resistance that they have found on human isolates. "It helped put credence to our conclusions that there isn't a link and if there is, it is not significant."

Trends in Europe

The report also says that the European ban on antibiotics to promote growth has not reduced antibiotic resistance levels in humans in Europe, U.S. data shows the incident of antibiotic resistant foodborne pathogens is generally declining as has the number of cases caused by food-borne bacteria.

"After examining the extensive surveillance data available, no significant benefits to human health as a result of European ban are evident, while it is clear that resistance in foodborne pathogens has decreased in the U.S.," Jones says.

Tollefson says that "Several studies demonstrating these effects will be published in 2004, but recent review articles on the human health consequences that have resulted from the use of antimicrobial agents in food animals is available." (Bazra and Travers, 2002; Travers and Bazra, 2002)

Tollefson adds, "Moreover, an expert consultation in December 2003 convened by FAO, International Office of Epizootics and the World Health Organization concluded 'there is clear evidence of adverse human health consequences due to resistant organisms resulting from on-human usage of antimicrobials.' "

Tony Cox, co-author and president of Cox Associates, an applied research company specializing in health risk analysis and operations research modeling, adds, "We agree with the World Health Organization and the International Office of Epizootics that sound policy decisions must be based on scientific risk assessments that address the likely future human health consequences of proposed risk management actions."

Waddell adds, "Continued use of antibiotics in food animals is important to animal health and welfare, and food safety. We will continue to follow the principles of prudent use and rely on surveillance and risk assessment to ensure safe use of antibiotics to keep animals healthy."

Related Content:

Regulatory
What you need to know about GFI #256 and the changing landscape of compounding medicine
What you need to know about GFI #256 and the changing landscape of compounding medicine
3 common misconceptions in controlled substance regulations
3 common misconceptions in controlled substance regulations
FDA hosts virtual listening session on regulation of animal food
FDA hosts virtual listening session on regulation of animal food

Advertisement

Latest News

Dogs and staff at Seattle dog resort safely escape fire

Pet safety for this Super Bowl Sunday

New video series informs pet owners on dog and cat nutrition

3 Must-reads for National Pet Dental Health Month

View More Latest News
Advertisement